The Biden Administration released a final rule on the 340B Drug Pricing Program administrative dispute resolution process. The federal government has created a healthcare anti-trust reporting portal for the public. And a major cancer institute has retracted several research studies. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
